[Combining venlafaxine and mirtazapine for the treatment of major depression with dysthymia--"double depression"].
Ladeira
Rodolfo Braga
RB
Cunha
Fernando Toledo
FT
Salgado
João Vinícius
JV
Teixeira
Antônio Lúcio
AL
Nicolato
Rodrigo
R
D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D003511:Cyclohexanols / Q000627:therapeutic use*; D003865:Major Depressive Disorder / Q000150:complications / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D019263:Dysthymic Disorder / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008803:Mianserin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000078785:Mirtazapine; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D000929:Antidepressive Agents, Tricyclic; D003511:Cyclohexanols; D008803:Mianserin; D000069470:Venlafaxine Hydrochloride; D000078785:Mirtazapine